COVID-19: Ghana begins mass vaccinations
Ghana has begun mass vaccinations after receiving 600,000 doses of the Oxford-AstraZeneca vaccines from the UN-backed Covax distribution initiative.
Tue, 02 Mar 2021 11:58:11 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
AI Generated Summary
- Mass vaccination campaign in Ghana aims to inoculate 20 million people by the end of the year, potentially easing restrictions and reviving economic activities
- Hospitality sector, one of the hardest-hit industries by the pandemic, stands to benefit from the vaccination drive by resuming operations and bouncing back financially
- Expectations for increased foreign direct investment in Ghana as the country moves towards immunization and seeks to attract investors through restored confidence and economic stability.
Ghana has embarked on a mass vaccination campaign after receiving 600,000 doses of the Oxford-AstraZeneca vaccine through the UN-backed Covax distribution initiative. President Nana Akufo-Addo encouraged citizens to embrace the vaccine, debunking conspiracy theories surrounding its safety and efficacy. Courage Kingsley Martey, Senior Economist at DataBank Group, shared insights on the implications of this vaccination drive on the country's economic landscape in an interview with CNBC Africa. Martey highlighted that while the current supply of vaccines is only sufficient for 300,000 people, Ghana aims to vaccinate 20 million individuals by the end of the year. This ambitious target equates to immunizing approximately 65% of the total population, a milestone that could potentially lead to the easing of restrictions and a resurgence in economic activities.